Recognition of the nonclassical MHC class I molecule H2-M3 by the receptor Ly49A regulates the licensing and activation of NK cells
Daniel M Andrews, Lucy C Sullivan, Nikola Baschuk, Christopher J Chan, Richard Berry, Claire L Cotterell, Jie Lin, Heloise Halse, Sally V Watt, Jennifer Poursine-Laurent, Chyung-Ru Wang, Anthony A Scalzo, Wayne M Yokoyama, Jamie Rossjohn, Andrew G Brooks, Mark J Smyth
Nature Immunology | NATURE PUBLISHING GROUP | Published : 2012
Awarded by US National Institutes of Health
We thank C. Paget for critical analysis of the manuscript; E. Hawkins, Q. Mundrea, B. Venville, N. McLaughlin and J. Sharkey for technical assistance; and B. Murphy (UC Davis Cancer Center) for the YE1/32 antibody to Ly49A. Supported by the National Health and Medical Research Council of Australia (D.M.A., L.C.S., R.B., M.J.S., A.G.B. and J.R.), Cancer Australia, the Cure Cancer Australia Foundation, the US National Institutes of Health (AI040310 to C.-R.W.) and the Howard Hughes Medical Institute (W.M.Y.).